In Academia, Innovators Receive Unfair Compensation for Their Discoveries

Bill Of Health

Biotechnology Intellectual Property Matt Bauer Research Funding patents universitiesBy Matt Bauer. In academia, many of the scientists who are recognized as inventors on patents see little economic gain from these agreements.

Decolonizing the Pandemic Treaty Through Vaccine Equity

Bill Of Health

By Tlaleng Mofokeng, Daniel Wainstock, and Renzo Guinto. In recent years, there have been growing calls to “ decolonize ” the field of global health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good 

Bill Of Health

By Ellen ‘t Hoen. The COVID-19 pandemic has laid bare the lack of regulation for the sharing of intellectual property (IP) and technology needed for an effective and equitable response to the crisis.

Promoting Vaccine Equity

Bill Of Health

By Ana Santos Rutschman. The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines against emerging pathogens.

Leverage COVID-19 Frameworks to Prepare for the Next Pandemic

Bill Of Health

Biotechnology Health Law Policy International Pharmaceuticals Public Health Research Funding Resource Allocation Vaccines COVID covid boosters covid pandemic infectious disease infectious disease surveillance mers pandemic preparedness pandemic prevention pandemic response sars SARS-CoV-2

Pig Hearts for Humans and the FDA

Bill of Health

Animal Research Biotechnology FDA Health Law Policy Organs Public Health Resource Allocation Organ Transplantation organ transplants xenotransplantationBy Jacob Balamut.

Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?

Bill of Health

Biotechnology Featured Genetics Health Information Technology History Intellectual Property Jorge Contreras Research Funding Scientific Evidence Supreme Court Vaccines aclu Association for Molecular Pathology v. By Jorge L. Contreras.

COVID ‘Compromise’ on International IP Underscores Need for New Approach

Bill of Health

By Cynthia M.

The Risk of Pervasive Trade Secret Practices Within the Life Sciences

Bill of Health

Biotechnology Health Law Policy Intellectual Property Matt Bauer biologics Biosimilars patents Trade SecretsBy Matt Bauer.

Lessons Learned from the COVID-19 Pandemic: The Future for Diagnostics

Bill of Health

Biotechnology CRISPR Matt Bauer Medical devices Public Health COVID-19 diagnostic tests Diagnostics mCARMEN pandemic pandemic diagnostics pcr rapid antigen testsBy Matthew Bauer and Nicole Welch. Diagnostic tests have changed in the eyes of many Americans across the COVID-19 pandemic.

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

At the research and development (R&D) stage, government funders can bind producers to equity goals through targeted contractual provisions, as we explain in a recently-published Nature Biotechnology article. By Sapna Kumar and Ana Santos Rutschman.

Call for Submissions: Journal of Law and the Biosciences Special Issue on Abortion Law

Bill Of Health

Announcements Bioethics Biotechnology Call for Abstracts Health Law Policy Petrie-Flom Center Public Health Publications Journal of Law and the Biosciences The Journal of Law and the BiosciencesAmerican law on reproduction seems likely to change, perhaps radically, in 2022, as the U.S.

Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic

Bill Of Health

By Brook K. Baker .

The Civil Rights Challenge to Gene Patenting

Bill Of Health

Myriad Genetics that naturally occurring DNA sequences are not patentable, a ruling that has had repercussions throughout the scientific community and the biotechnology industry. Register now for tomorrow’s discussion of The Genome Defense ! By Jorge L. Contreras.

Call for Submissions: Journal of Law and the Biosciences Special Issue on Abortion Law

Bill of Health

Announcements Bioethics Biotechnology Call for Abstracts Health Law Policy Petrie-Flom Center Public Health Publications Journal of Law and the Biosciences The Journal of Law and the BiosciencesAmerican law on reproduction seems likely to change, perhaps radically, in 2022, as the U.S.

Biotech R&D Platform Benchling Closes $100M at $6B Valuation

HIT Consultant

Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. Biotechnology is rewriting life as we know it.

CareMetx Acquires Patient Adherence Platform Human Care Systems

HIT Consultant

HCS), a company focused on helping patients adhere to and benefit from pharmaceutical and biotechnology products. What You Should Know: – Strategic acquisition of leading patient adherence technology and services provider to complement CareMetx current suite of patient access products.

VivoSense Raises $25M for Wearable Sensor Biomarkers to Advance Clinical Trials

HIT Consultant

VivoSense interprets and contextualizes data gathered directly from the patient and makes it available to clinical researchers in pharma and biotechnology.

Lightship Raises $40M to Bring Decentralized Clinical Trials at Scale

HIT Consultant

The firm is continuing to add new pharmaceutical and biotechnology companies to its client base, in new therapeutic areas, and has continued to expand with the addition of over 100 new employees so far in 2021.

There’s More to Decision-Making Capacity than Cognitive Function

Bill Of Health

The Health Law, Policy, Bioethics, and Biotechnology Workshop provides a forum for discussion of new scholarship in these fields from the world’s leading experts.

Petrie-Flom Welcomes 2021-2022 Student Fellows

Bill Of Health

These six students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. (Clockwise from top left: Matt Bauer, Jack Becker, Bailey Kennedy, Cathy Zhang, Leah Pierson, Kaitlynn Milvert).

Graduate Students’ Curricula Should Include Intellectual Property

Bill of Health

Potentially the most relevant case for teaching students about IP is that they may want to leverage this knowledge to turn their laboratory discoveries into new biotechnology companies. By Matt Bauer.

The 8 Unicorns In Healthcare And Biotech

Perficient Digital Transformation

Of these unicorns, 80 fall into the category of healthcare and biotechnology. Let’s talk about unicorns. What do unicorns have to do with business? According to Investopedia, a unicorn is an organization that has a valuation of more than $1 billion.

Perspectives on Data Privacy for Direct-to-Consumer Health Apps

Bill Of Health

She previously served as a Research Fellow in Medicine, Artificial Intelligence, and Law at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School for the Project on Precision Medicine, Artificial Intelligence, and the Law ( PMAIL ).

Fresenius Medical Invests Additional $25M in Biotech Platform Humacyte

HIT Consultant

What You Should Know: Fresenius Medical Care (FMC) today announced its plans to invest an additional $25 million in clinical-stage biotechnology platform company Humacyte following the extension of its collaboration in June.

Psychedelic Policy on the Federal Level: Key Takeaways from a Petrie-Flom Center Panel

Bill of Health

To navigate the myriad interests and stakes involved in creating federal psychedelic policy, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School convened a virtual panel discussion with three leading psychedelic policy advocates. By James R. Jolin.

PostEra Secures $24M, Forms $260M AI Lab Collaboration with Pfizer

HIT Consultant

What You Should Know: – PostEra , a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients.

GoMo Health Acquires Trajectory, a Specialist Health and Wellness Agency

GoMoHealth

NEWS RELEASE. November 15, 2021. Contact: Shelley R. Schoenfeld, Chief Marketing Officer. Ph: 732-484-9144. Email: sschoenfeld@gomohealth.com. GoMo Health Acquires Trajectory, a Specialist Health and Wellness Agency.

Pregnancy Loss, Abortion Rights, and a Holistic Reproductive Justice Movement

Bill Of Health

The Health Law, Policy, Bioethics, and Biotechnology Workshop provides a forum for discussion of new scholarship in these fields from the world’s leading experts.

Verana Health Raises $150M to Expand Real-World Data Network

HIT Consultant

Verana Health is the exclusive data partner of the American Academy of Ophthalmology, American Urological Association, and American Academy of Neurology and collaborates with multinational pharmaceutical companies as well as emerging biotechnology and biopharmaceutical companies.

Legal Capacity and Persons with Disabilities’ Struggle to Reclaim Control over Their Lives

Bill Of Health

The Health Law, Policy, Bioethics, and Biotechnology Workshop provides a forum for discussion of new scholarship in these fields from the world’s leading experts.

AI and machine learning can implement positive change for the broader health ecosystem

Cloud Blogs

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. When communities have access to better data, they can make better decisions.

Addressing Information Overload: Personalize Interactions in the Moments That Matter

Perficient Digital Transformation

In the previous part of this series, we discussed how enterprise search can accelerate innovation with a single source of truth. In this part, we will explore the fifth and final way to address information overload with AI-powered search: personalize interactions in the moments that matter.

Uber Health Hires First Chief Medical Officer, Aledade’s New CEO, Other Digital Health Appointments

HIT Consultant

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. Michael Cantor.

Addressing Information Overload: Facilitate Easier Information Retrieval With AI-Powered Search

Perficient Digital Transformation

Do you spend hours each month searching for, but not always finding, the information you need to do your job? These are often not just ‘like-to-have’ files, but rather those that you actually need to complete your work.